Oxygen therapy, capillary rarefaction and blood pressure rise in premature low birth weight infants: is there a link?

2019 ◽  
Vol 33 (12) ◽  
pp. 821-823
Author(s):  
Panagiota Anyfanti ◽  
Eugenia Gkaliagkousi ◽  
Stella Douma
Heart ◽  
2017 ◽  
Vol 103 (Suppl 5) ◽  
pp. A75-A76 ◽  
Author(s):  
Rajendra Raghuraman ◽  
Donovan Duffy ◽  
Isaac Manyondaa ◽  
Tarek Antonios

2019 ◽  
Vol 34 (4) ◽  
pp. 278-285 ◽  
Author(s):  
Rajendra P. Raghuraman ◽  
Donovan Duffy ◽  
Veronica A. Carroll ◽  
Isaac Manyonda ◽  
Tarek F. Antonios

PEDIATRICS ◽  
1973 ◽  
Vol 51 (6) ◽  
pp. 1032-1036 ◽  
Author(s):  
Virginia Borromeo-McGrail ◽  
Joseph Bordiuk ◽  
Hans Keitel

The effect of ophthalmic instillation of 10% phenylephrine on systemic blood pressure in the neonate has not been previously evaluated, despite reports of adverse reactions. The effect of 10% and 2½% phenylephrine eye drops in healthy low birth weight neonates was compared in a double-blind study. Blood pressure showed a rise of 12 to 16 mm Hg in systole and 10 to 14 mm Hg in diastole following administration of 10% phenylephrine. Blood pressure remained stable in infants receiving 2½% phenylephrine. Consistent, although more variable, increases in blood pressure were noted in eight low birth weight infants given 10% phenylephrine eye drops in a nonblind study. Complete mydriasis was achieved with 2½% phenylephrine as well as with 10%. Neither concentration had an effect on pulse or respiratory rates. Cutaneous administration of either 10% or 2½% phenylephrine to abdominal skin produced local blanching but no systemic effect. To avoid potentially dangerous sequelae from iatrogenic hypertension, it is recommended that not more than one drop of 2½% phenylephrine in each eye be administered to neonates for mydriasis.


2011 ◽  
Vol 26 (7) ◽  
pp. 1115-1121 ◽  
Author(s):  
Andrea F. Duncan ◽  
Roy J. Heyne ◽  
Janet S. Morgan ◽  
Naveed Ahmad ◽  
Charles R. Rosenfeld

Sign in / Sign up

Export Citation Format

Share Document